Tuesday, June 15, 2021
HomeGermany suspends use of AstraZeneca Covid-19 vaccine over reports of blood-clotting issues

Germany suspends use of AstraZeneca Covid-19 vaccine over reports of blood-clotting issues

[ad_1]

Germany is suspending use of AstraZeneca vaccine after the national regulator advised that reports of blood clots should be investigated.

The announcement on Monday came after Ireland, Denmark, Norway and Iceland already moved to suspend the jab following blot-clotting issues, some of them fatal, in people who had used it.

The Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca vaccine, hours after the government put its vaccination programme on hold following reports of potential side-effects in other countries.

Meanwhile Denmark has reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.

Iceland and Bulgaria had earlier suspended its use while Austria, along with Italy, have stopped using particular batches.

However France, Germany and the United Kingdom say they have no concerns about jab.

Prosecutors in the northern Italian region of Piedmont said on Monday they have seized a batch of 393,600 shots of the AstraZeneca Covid-19 vaccine following the death of a man hours after he had received the jab.

Piedmont’s regional government suspended use of the batch on Sunday after Sandro Tognatti, a 57-year-old music teacher, fell ill and died in circumstances that have not yet been clarified.

The European Medicines Agency has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to five million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.

The small number of reported side-effects in Europe have upset vaccination programmes already under pressure over slow rollouts and vaccine scepticism in some countries.

AstraZeneca Plc said earlier it had conducted a review covering more than 17 million people vaccinated in the European Union and the UK which had shown no evidence of an increased risk of blood clots.

[ad_2]

Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments